INTRODUCTION
Mycoplasma bovis has been described as the aetiological agent of severe bovine diseases, such as mastitis of cows, arthritis and pneumonia of calves and young cattle, as well as genital disorders in bulls and cows (18, 21, 26, 27) . Mycoplasmal diseases are characterised by severe clinical symptoms and resistance to therapy. No effective immunoprophylactic measures are known. These circumstances make effective control of the infection very difficult, and the economic losses caused are often considerable (1, 4, 12) . It should be further noted that, in addition to specific control measures, the observation of a high standard of veterinary hygiene is an essential prerequisite for the prevention of M. bovis infections. Due to non-specific clinical symptoms and great variation in epizootiology and pathogenesis, each disease caused by M. bovis requires a specific diagnostic approach and specific control measures. This situation is illustrated in Table I , which also contains a summary of the diagnostic methods used. At present, mastitis caused by M. bovis is controlled mainly by the culling of all cows shedding the agent via milk. Detection of shedders at a very early stage of disease is crucial for this method of control, and single-animal diagnosis is essential if control is to be effective. In the case of arthritis and pneumonia caused by M. bovis, control can be achieved through early herd entry restrictions based on the findings of comprehensive livestock monitoring (i.e. herd diagnosis), and shedders no longer need to be selectively culled. The main control measures for genital diseases caused by M. bovis include mycoplasma decontamination of semen (17, 28, 29) and, if inevitable, culling of shedders. As for mastitis, early identification (i.e. single-animal diagnosis) of all animals shedding M. bovis via the genital tract is a necessary precondition for successful control. Consequently, there is a need to develop new diagnostic procedures which are not only more rapid but also more specific than existing techniques.
In the present paper, the authors describe three diagnostic methods applicable for the detection of M. bovis and other mycoplasmas, and compare the main parameters of performance on the basis of experience gained through several research projects in recent years. The main results and conclusions are summarised in Table II . 
CONVENTIONAL METHODS OF DETECTION
To date, routine diagnosis of M. bovis infection has been performed exclusively by conventional culture methods subsequent to mycoplasma isolation (11, 30) . However, these methods are laborious and time-consuming and can be impaired by bacterial contamination of the samples. The most serious drawback of such methods is that the final results are available only after several days -as long as five to ten days in unfavourable circumstances. Nevertheless, culture methods will remain important for routine use in laboratories, as the high specificity and sensitivity (l0 colonyforming units [CFU]/ml) of these tests ensure reliable detection of the pathogen from a wide variety of clinical specimens. M. bovis isolation can be a useful tool for singleanimal diagnosis and will serve as the basis for control of mycoplasmal mastitis until more rapid routine diagnostic assays are introduced. Furthermore, culture methods are suitable for simultaneous detection of several mycoplasma species present in the same sample.
As a conventional alternative to antigen detection, antibodies against M. bovis in blood and milk can be detected by enzyme-linked immunosorbent assay (ELISA) techniques (5, 40) . These are generally less labour-intensive and time-consuming than culture methods and allow the screening of large numbers of samples; results are normally available within two days. The authors developed an ELISA for M. bovis antibodies using whole-cell antigen of the agent for solid-phase coating (7) . The assay has proved sufficiently specific and the sensitivity of detection (10 5 -10 6 CFU/ml) was 100 times greater than with other serological methods, such as film inhibition and indirect haemagglutination. However, the application of antibody detection ELISAs is limited by the fact that antibody titres only emerge ten to fourteen days after the onset of disease. Consequently, the pathogen cannot be detected during the incubation period. The attainable sensitivity is insufficient for reliable identification of all animals shedding M. bovis. Nevertheless, ELISA detection of antibodies can be a useful method for regular screening of M. bovis-free herds for trade purposes and livestock monitoring in general.
PROTEIN ANTIGEN-BASED METHODS OF DETECTION
The specificity of conventional antigen ELISAs can be improved by targetting a particular protein rather than the whole complex of cellular proteins (6, 14) . Earlier investigations suggested involvement of a 26 kDa surface protein, p26, in the cell adherence process of M. bovis (35) . Using a monoclonal antibody directed against the p26 antigen, the authors developed an antigen capture ELISA which was successfully employed for the detection of M. bovis in bovine milk (3, 13) . The assay has proved highly specific, with cross-reactions being confined to M. agalactiae. The latter should not be relevant in the diagnosis of bovine diseases, as M. agalactiae is known to be strongly adapted to sheep and goats. Bacterial contamination of the sample was not found to impair M. bovis detection in any way. Since the whole ELISA procedure is sufficiently rapid (one to three days) and can be conducted in normally equipped diagnostic laboratories, it is well suited for screening examinations involving large numbers of samples. Given the comparatively low sensitivity (10 5 CFU/ml), the normal protocol can only be recommended for the screening of milk samples from cows with clinical mastitis. However, pre-incubation of the samples for 24 h or 48 h can improve detection limits by two orders of magnitude. In this variant, the antigen capture ELISA has proved suitable for single-animal diagnosis of M. bovis mastitis by the screening of diseased cows and high-level shedders, as well as for complete herd monitoring.
Whole-cell protein analysis by sodium dodecyl sulphate-polyacrylamide gel electrophoresis (SDS-PAGE) and/or immunoblotting is widely used to characterise the antigen repertoire of individual bacterial strains, including mycoplasmal isolates (8, 20, 25, 39) . The procedure is characterised by high specificity, which allows the differentiation of distinct groups within a species. On the basis of individual banding patterns, it is possible to identify and classify, or trace the presumed origin of strains. Such analyses can provide useful indications concerning antigenic relationships within and between species. For an assessment of the scope of intraspecies antigen variability the authors compared whole-cell protein SDS-PAGE and immunoblot patterns for thirty-four field isolates of M. bovis (34) . The main conclusion was that antigenic variation within this group of strains was mostly confined to quantitative differences; the concentrations of certain antigen clusters in the molecular weight ranges of 64-68 kDa, 55 kDa and 26 kDa varied between individual strains. It can be assumed that this phenomenon is part of a very versatile and complex mechanism of surface antigen variation in M. bovis as recently discovered by Rosengarten and colleagues (33) . As far as the use of whole-cell protein analysis for diagnostic purposes is concerned, several essential limitations must be taken into account, including: -low sensitivity (approximately 10 6 CFU/ml) -the impossibility of direct M. bovis detection in clinical material -the necessity for cultivation of the isolate strain in each case -the difficulty of standardisation.
On the other hand, the information provided by a protein pattern is quite extensive with regard to all major antigens, thus making whole-cell protein analysis a suitable tool for research in the fields of epizootiology and pathogenesis.
DNA-BASED DIAGNOSIS OF MYCOPLASMA INFECTION
In recent years, there has been a virtual revolution in methods for the detection of bacteria, viruses and other micro-organisms, as a consequence of the use of new molecular biology techniques. In view of the potential of these methods, it is widely agreed that deoxyribonucleic acid (DNA)-based diagnosis of mycoplasmal diseases is emerging as the diagnostic tool of choice for the future. A large number of different methodological approaches to mycoplasma detection are described in the literature, involving hybridisation assays with DNA or ribonucleic acid (RNA) probes (9, 10, 16, 19, 22, 24, 31, 32, 36, 37, 38) or DNA in vitro amplification by the polymerase chain reaction (PCR) (2,23).
The authors have developed a variety of specific nucleic acid probes for the detection of M. bovis, which have been used in filter dot blot and solution hybridisation. Furthermore, primer sets derived from these probes have been employed for PCR detection of the agent. This research is described in detail elsewhere in this issue of the Review (15). The results indicated that although filter dot blot hybridisation is highly specific for extracted DNA of M. bovis, it is not suitable for assaying biological samples, as the selective binding of DNA to the membrane is severely disturbed by proteins and other substances present in the material. Solution hybridisation with RNA probes was used by the authors to screen large numbers of experimentally-infected milk samples. Although the results achieved to date have not been completely satisfactory (Table II) , this method is still considered potentially applicable for the routine diagnosis of samples containing mycoplasmas; particular advantages of such a procedure would be rapidity (one or two days) and high specificity. However, sensitivity of detection was found to range between 10 5 and 10 6 CFU/ml in our experiments, which is not usually sufficient to detect the low levels of mycoplasma which occur during the incubation period or in chronically-diseased animals. Moreover, radioactive labelling of the probes is still required in most cases to attain reasonable sensitivity; such a practice is detrimental to any normal use in the laboratory. The sensitivity of this method cannot be expected to be increased much further because of the background problems with biological samples referred to above.
As with hybridisation assays, PCR detection of M. bovis in milk was seriously hampered by the interference of proteins, fats and probably also ions present in the milk. Various approaches were attempted to minimise this interference, and in a series of experiments involving protease pre-treatment it was shown that direct detection of M. bovis from milk is possible using PCR. This procedure detected 10 7 CFU/ml, but further optimisation is possible. While there can be no doubt that PCR is potentially the most sensitive of the methods discussed in this paper, it must be emphasised that there are often unrealistic expectations concerning the detection limit of this technique. For PCR, only a few microlitres of the sample can be taken,'so that even if at optimal conditions the DNA of a single mycoplasma cell is amplified and detected, the overall detection limit will be approximately 10 3 CFU/ml. The latter can be lowered only if DNA pre-enrichment steps are introduced. Nevertheless, PCR should be the method of choice for mycoplasma detection from biological samples, as it can be performed very rapidly (in one day) and is extremely specific for the target species; even differentiation of individual strains within a species is possible if appropriate probes are available. PALABRAS CLAVE: Amplificación en cadena por polimerasaDiagnóstico de laboratorio -ELISA -Especificidad -Hibridación del ácido desoxirribonucleico -Mycoplasma bovis -Pleuroneumonía contagiosa bovina -Sensibilidad -Sondas nucleicas.
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